These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

515 related articles for article (PubMed ID: 32192612)

  • 21. Knowledge, Attitude, and Practices regarding Pharmacovigilance and Adverse Drug Reaction reporting among Dental Students in a Teaching Hospital, Jodhpur, India: A Cross-sectional Study.
    Chhabra KG; Sharma A; Chhabra C; Reddy JJ; Deolia SG; Mittal Y
    J Contemp Dent Pract; 2017 Oct; 18(10):964-969. PubMed ID: 28989138
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An exploratory study of knowledge, attitudes, practice and barriers towards adverse drug reaction reporting among healthcare professionals in Malta.
    Curtolo E; Micallef B; Szijj JV; Serracino-Inglott A; Borg JJ
    Int J Risk Saf Med; 2024; 35(3):271-286. PubMed ID: 38820023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ADVERSE DRUG REPORTING IN COMMUNITY PHARMACY PRACTICE IN THE POMERANIAN DISTRICT IN POLAND.
    Zimmermann A; Gaworska-Krzeminska A; Flis A
    Acta Pol Pharm; 2016 Sep; 73(5):1389-1396. PubMed ID: 29638080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Utilization of and barriers to public sector tuberculosis services in India.
    Dandona R; Dandona L; Mishra A; Dhingra S; Venkatagopalakrishna K; Chauhan LS
    Natl Med J India; 2004; 17(6):292-9. PubMed ID: 15736548
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exploring the community pharmacist's knowledge, attitude, and practices regarding adverse drug reactions and its reporting in the United Arab Emirates: a survey-based cross-sectional study.
    Shareef J; Sridhar SB; Bhupathyraaj M; Shariff A; Thomas S
    Ther Adv Drug Saf; 2024; 15():20420986241285930. PubMed ID: 39381061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adverse drug reaction monitoring: support for pharmacovigilance at a tertiary care hospital in Northern Brazil.
    Lobo MG; Pinheiro SM; Castro JG; Momenté VG; Pranchevicius MC
    BMC Pharmacol Toxicol; 2013 Jan; 14():5. PubMed ID: 23298396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Profile of adverse drug reactions in drug resistant tuberculosis from Punjab.
    Bhushan B; Chander R; Kajal NC; Ranga V; Gupta A; Bharti H
    Indian J Tuberc; 2014 Oct; 61(4):318-24. PubMed ID: 25675695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A retrospective analysis of reporting of adverse drug reactions to oncology drugs: An experience from a national center of clinical excellence.
    Sharma PK; Misra AK; Gupta A; Singh S; Dhamija P; Pareek P
    Indian J Pharmacol; 2018; 50(5):273-278. PubMed ID: 30636831
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse drug reactions reported to a provincial public health sector pharmacovigilance programme in South Africa.
    Jones J; Swart A; Tommy E; Cohen K; Stewart A; Voget J; Blockman M
    S Afr Med J; 2020 Nov; 110(12):1226-1230. PubMed ID: 33403970
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Enhancing Pediatric Adverse Drug Reaction Documentation in the Electronic Medical Record.
    Tillman EM; Suppes SL; Feldman K; Goldman JL
    J Clin Pharmacol; 2021 Feb; 61(2):181-186. PubMed ID: 32776356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Strengthening the Bolivian pharmacovigilance system: New surveillance strategies to improve care for Chagas disease and tuberculosis.
    Cortes-Serra N; Saravia R; Grágeda RM; Apaza A; González JA; Ríos B; Gascón J; Torrico F; Pinazo MJ
    PLoS Negl Trop Dis; 2020 Sep; 14(9):e0008370. PubMed ID: 32956348
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The knowledge and attitude of the Turkish community pharmacists toward pharmacovigilance in the Kadikoy district of Istanbul.
    Toklu HZ; Uysal MK
    Pharm World Sci; 2008 Oct; 30(5):556-62. PubMed ID: 18350373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. "Side effects--part of the package": a mixed methods approach to study adverse events among patients being programmatically treated for DR-TB in Gujarat, India.
    Jakasania A; Shringarpure K; Kapadia D; Sharma R; Mehta K; Prajapati A; Kathirvel S
    BMC Infect Dis; 2020 Dec; 20(1):918. PubMed ID: 33267826
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety of medicines-Pharmacists' knowledge, practice, and attitudes toward pharmacovigilance and adverse drug reactions reporting process.
    Kopciuch D; Zaprutko T; Paczkowska A; Ratajczak P; Zielińska-Tomczak Ł; Kus K; Nowakowska E
    Pharmacoepidemiol Drug Saf; 2019 Dec; 28(12):1543-1551. PubMed ID: 31148344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contact screening and chemoprophylaxis in India's Revised Tuberculosis Control Programme: a situational analysis.
    Banu Rekha VV; Jagarajamma K; Wares F; Chandrasekaran V; Swaminathan S
    Int J Tuberc Lung Dis; 2009 Dec; 13(12):1507-12. PubMed ID: 19919768
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Patients pathways to tuberculosis diagnosis and treatment in a fragmented health system: a qualitative study from a south Indian district.
    Yellappa V; Lefèvre P; Battaglioli T; Devadasan N; Van der Stuyft P
    BMC Public Health; 2017 Aug; 17(1):635. PubMed ID: 28778192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reasons for interruption of anti-tubercular treatment among the retreatment patients in category II of RNTCP in Chandigarh, north India.
    Sarpal SS; Goel NK; Kumar D; Janmeja AK
    Indian J Tuberc; 2014 Apr; 61(2):121-8. PubMed ID: 25509934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of Knowledge, Attitudes, and Practices about Pharmacovigilance among Community Pharmacists in Qassim, Saudi Arabia.
    Abdulsalim S; Farooqui M; Alshammari MS; Alotaibi M; Alhazmi A; Alqasomi A; Altowayan WM
    Int J Environ Res Public Health; 2023 Feb; 20(4):. PubMed ID: 36834240
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Community Pharmacists' Views and Experiences with ADR Reporting for Complementary Medicines: A Qualitative Study in New Zealand.
    Barnes J; Butler R
    Drug Saf; 2020 Nov; 43(11):1157-1170. PubMed ID: 32975740
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Knowledge and awareness of adverse drug reactions and pharmacovigilance practices among healthcare professionals in Al-Madinah Al-Munawwarah, Kingdom of Saudi Arabia.
    Abdel-Latif MM; Abdel-Wahab BA
    Saudi Pharm J; 2015 Apr; 23(2):154-61. PubMed ID: 25972735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.